Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:4-[5-(2-chlorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid
go back to main search page
Accession:CHEBI:93598 term browser browse the term
Definition:An oxadiazole that has formula C15H9ClN2O3.
Synonyms:related_synonym: Formula=C15H9ClN2O3;   InChI=1S/C15H9ClN2O3/c16-12-4-2-1-3-11(12)14-17-13(18-21-14)9-5-7-10(8-6-9)15(19)20/h1-8H,(H,19,20);   InChIKey=DBPJEBCHIMBDSU-UHFFFAOYSA-N;   SMILES=C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC=C(C=C3)C(=O)O)Cl
 xref: LINCS:LSM-4053


show annotations for term's descendants       view all columns           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19734
    chemical entity 19732
      molecular entity 19729
        polyatomic entity 19639
          molecule 19452
            cyclic compound 19228
              ring assembly 6890
                4-[5-(2-chlorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19734
    subatomic particle 19730
      composite particle 19730
        hadron 19730
          baryon 19730
            nucleon 19730
              atomic nucleus 19730
                atom 19730
                  main group element atom 19614
                    p-block element atom 19614
                      carbon group element atom 19506
                        carbon atom 19500
                          organic molecular entity 19500
                            organic molecule 19418
                              organic cyclic compound 19189
                                organic heterocyclic compound 18267
                                  organic heteromonocyclic compound 16353
                                    oxadiazole 17
                                      4-[5-(2-chlorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.